Literature DB >> 2573615

Expression of transcripts encoding a parathyroid hormone-related peptide in abnormal human parathyroid tissues.

K Ikeda1, A Arnold, M Mangin, B Kinder, N A Vydelingum, M F Brennan, A E Broadus.   

Abstract

A PTH-related peptide (PTHRP) has been identified and its cDNA cloned from human tumors associated with the syndrome of humoral hypercalcemia of malignancy. The human PTHRP gene has been recently isolated and found to be a complex transcriptional unit using multiple promoters and containing alternatively spliced 3' exons which result in three mRNA classes, each class encoding a PTHRP with a unique carboxy-terminus. The PTHRP gene appears to be expressed in a number of normal tissues, and PTHRP transcripts have been previously reported to be overexpressed in a small sample of human parathyroid adenomas. In the present study we surveyed RNA prepared from a total of 60 abnormal human parathyroid glands for PTHRP gene expression using a combination of Northern blotting and RNase protection techniques. Apparent overexpression of PTHRP mRNA was observed in two thirds of parathyroid adenomas, whereas no overexpression was found in 7 examples of sporadic primary hyperplasia, 5 examples of secondary hyperplasia, and 3 examples of parathyroid carcinoma. Apparent overexpression was also observed in 1 of 4 cases of multiple endocrine neoplasia type 1, 1 of 2 examples of multiple endocrine neoplasia type 2, and 1 gland considered to represent tertiary hyperparathyroidism. Northern analysis of poly(A)+ RNA prepared from three representative adenomas using region-specific probes indicated that two putative promoters are used and revealed a pattern of preferential splicing of transcripts to include the most distal 3' exon. These findings suggest that the PTHRP gene is commonly overexpressed in adenomatous parathyroid glands, but not in sporadic primary hyperplasia, that this overexpression does not seem to be dependent on the use of a single specific promoter, and that adenomatous parathyroid cells appear to preferentially use one of several alternative splicing pathways. It is presently not known whether PTHRP is secreted by abnormal parathyroid tissues and, if so, in what form.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573615     DOI: 10.1210/jcem-69-6-1240

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Immunohistochemicaf evidence of parathyroid hormone-related protein in human parathyroid tissue.

Authors:  Per Hellman; Gunnel Bjerneroth; Claes Juhlin; Peter Ridefelt; Jonas Rastad; Göran Åkerström; Harald Jüppner
Journal:  Endocr Pathol       Date:  1990-09       Impact factor: 3.943

Review 2.  Parathyroid hormone-like peptide.

Authors:  Daniel J Drucker
Journal:  Endocr Pathol       Date:  1991-03       Impact factor: 3.943

Review 3.  PTHrP gene expression in cancer: do all paths lead to Ets?

Authors:  Virgile Richard; Thomas J Rosol; John Foley
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2005       Impact factor: 1.807

4.  Inhibition of parathyroid hormone-related protein release by extracellular calcium in dispersed cells from human parathyroid hyperplasia secondary to chronic renal failure and adenoma.

Authors:  H Matsushita; M Hara; K Honda; M Kuroda; M Usui; H Nakazawa; S Hara; Y Shishiba
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

5.  Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level.

Authors:  Angela Gurrado; Andrea Marzullo; Germana Lissidini; Agostino Lippolis; Domenico Rubini; Gaetano Lastilla; Mario Testini
Journal:  World J Surg Oncol       Date:  2008-02-21       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.